These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36274994)

  • 1. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 4. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
    Barjaktarevic IZ; Buhr RG; Wang X; Hu S; Couper D; Anderson W; Kanner RE; Paine Iii R; Bhatt SP; Bhakta NR; Arjomandi M; Kaner RJ; Pirozzi CS; Curtis JL; O'Neal WK; Woodruff PG; Han MK; Martinez FJ; Hansel N; Wells JM; Ortega VE; Hoffman EA; Doerschuk CM; Kim V; Dransfield MT; Drummond MB; Bowler R; Criner G; Christenson SA; Ronish B; Peters SP; Krishnan JA; Tashkin DP; Cooper CB;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2927-2938. PubMed ID: 31908441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization
    Lu R; Li Y; Hu C; Pan P; Zhao Q; He R
    Ther Adv Respir Dis; 2023; 17():17534666231214134. PubMed ID: 38073272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.
    Chaiwong W; Deesomchok A; Pothirat C; Duangjit P; Liwsrisakun C
    Respir Med; 2023 Dec; 220():107460. PubMed ID: 37949150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.
    Beasley R; Hughes R; Agusti A; Calverley P; Chipps B; Del Olmo R; Papi A; Price D; Reddel H; Müllerová H; Rapsomaniki E
    Am J Respir Crit Care Med; 2024 Feb; 209(4):390-401. PubMed ID: 38029294
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the difference between FEV1 change in percentage predicted value and change over baseline in the assessment of bronchodilator responsiveness in patients with COPD?
    Jian W; Zheng J; Hu Y; Li Y; Gao Y; An J
    J Thorac Dis; 2013 Aug; 5(4):393-9. PubMed ID: 23991293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease.
    Reid DW; Soltani A; Johns DP; Bish R; Williams TJ; Burns GP; Walters EH
    Intern Med J; 2003 Dec; 33(12):572-7. PubMed ID: 14656230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of bronchodilator responsiveness of the small airway (using mid-maximal expiratory flow) in COPD - a retrospective study.
    Alobaidi NY; Almeshari MA; Stockley JA; Stockley RA; Sapey E
    BMC Pulm Med; 2022 Dec; 22(1):493. PubMed ID: 36585669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator Reversibility in the GAN Severe Asthma Cohort.
    Milger K; Skowasch D; Hamelmann E; Mümmler C; Idzko M; Gappa M; Jandl M; Körner-Rettberg C; Ehmann R; Schmidt O; Taube C; Holtdirk A; Timmermann H; Buhl R; Korn S
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):446-456. PubMed ID: 36000830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China.
    Zhang S; Hu C; Lu R; Niu R; Hu X; Qin L; He R; Feng J
    Adv Ther; 2018 Oct; 35(10):1578-1584. PubMed ID: 30209751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.
    Annangi S; Coz-Yataco AO
    Respir Care; 2022 Apr; 67(4):440-447. PubMed ID: 35338095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters.
    Kraemer R; Smith HJ; Gardin F; Barandun J; Minder S; Kern L; Brutsche MH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2487-2500. PubMed ID: 34511893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Impact of the Updated 2021 European Respiratory Society/American Thoracic Society Criteria on Bronchodilator Responsiveness in Asthma.
    Trepić N; Nemet M; Vukoja M
    Cureus; 2024 Aug; 16(8):e66844. PubMed ID: 39280484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.